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A B S T R A C T
Infections caused by avian pathogenic Escherichia coli (APEC) cause important economic
losses to poultry industry.
The studies presented herein, aimed at investigating the in vivo performance of a
cocktail of three phages in treating severe respiratory E. coli infections in experimentally
contaminated birds and naturally infected ﬂocks.
Three lytic coliphages, phi F78E (Myoviridae), phi F258E (Siphoviridae) and phi F61E
(Myoviridae) were combined in a 5.0 107 PFU/ml cocktail to be used in naturally APEC
infected ﬂocks (refractive to antibiotherapy). Experimentally infected birds were treated
with phi F78E at two different titres (107 PFU/ml and 109 PFU/ml). Phage administration
was performed orally and by spray, in a single application. The morbidity, mortality and
pathology scores were compared with control birds not receiving phage therapy.
The results revealed that the success of phage therapy in experimental rooms was
dosage dependent, being 107 PFU/ml not enough to treat the infected chickens whereas a
concentration of 109 PFU/ml of phi F78E allowed a decrease of 25% and 43% in chickens’
mortality and morbidity, respectively. In the large scale experiments, the results obtained
showed a remarkable efﬁcacy of the low titre phage cocktail (107 PFU/ml) in decreasing
the ﬂocks’ mortality to levels below 0.5% in no more than 3 weeks, with no recidivism.
Based on the results we can conclude that phage treatment is a valuable alternative to
control APEC infections in poultry.
 2010 Elsevier B.V. All rights reserved.
Contents lists available at ScienceDirect
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Escherichia coli (E. coli) is a commensal bacterium of
chickens’ intestine. However, some strains, extra-intesti-
nal avian pathogenic E. coli (APEC), are able to trigger
invasive infections outside the intestine, namely coliba-
cillosis (Barnes and Gross, 1997; Zhao et al., 2005). This
disease is responsible for important economic losses in the
poultry industry worldwide, due to lowered production,
high treatment costs, carcass rejection at processing and
mortality (Vandekerchove et al., 2004; Roy et al., 2006).* Corresponding author. Tel.: +351 253 604419; fax: +351 253 678986.
E-mail address: jazeredo@deb.uminho.pt (J. Azeredo).
0378-1135/$ – see front matter  2010 Elsevier B.V. All rights reserved.
doi:10.1016/j.vetmic.2010.05.015Antibiotic therapy is being used to control this
infection, however a signiﬁcant increase in drug-resistant
E. coli strains, the restriction to the antibiotic usage
implemented by the European Union and the reduced
number of new active ingredients entering the market
(Scioli et al., 1983; Van den Bogaard et al., 2001) have been
limiting its therapeutic effectiveness (Pucci et al., 2004).
Bacteriophages (phages), virus infecting bacteria, have
been proposed as valuable candidates as therapeutic
agents, based on their capacity to invade and disrupt
bacterial metabolism causing the bacteria lysis. Phages are
host speciﬁc, preventing the destruction of most of the
healthy ﬂora, and they are able tomultiply exponentially at
the site of infection. Phages are harmless for animals,
plants and for the environment (Sulakvelidze et al., 2001).
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by numerous authors. In vivo conﬁned experimental trials
have been undertaken to establish the proof of principle of
bacteriophage therapy in treating different animals against
different types of bacteria (Smith and Huggins, 1983;
Smith et al., 1987, Soothill et al., 1988; Soothill, 1992; Sklar
and Joerger, 2001; Huff et al., 2002, 2003, 2004; Park and
Nakai, 2003; Ronda et al., 2003).
In this work, in vivo trials were performed in order to
determine the efﬁcacy of three phages, phi F78E (Myovir-
idae), phi F258E (Siphoviridae) and phi F61E (Myoviridae),
administered orally and by spray, in treating chickens
suffering from colibacillosis.
2. Materials and methods
2.1. Isolation of APEC strains
E. coli strains were isolated from poultry carcasses with
colibacillosis, exhibiting typical postmortem lesions as
perihepatitis, pericarditis, aerosacculitis and enteritis.
Samples of livers, spleen and lungs were collected from
carcasses, emulsiﬁed in sterile saline solution (0.85% NaCl)
and 0.1ml of supernatant was plated on MacConkey agar
(Biokar Diagnostics), a selective and differential medium
for Gram-negative bacteria. Plates were incubated over-
night at 37 8C. As E. coli is a lactose fermenter bacteria, the
species conﬁrmation of the isolates were conducted by
selecting pink-red colonies from the referred media and
using API E20 strips, according to manufacturer’s instruc-
tions (Bio-Merieux). E. coli isolates were stored in Nutrient
Broth (Oxoid) with 20% glycerol, at 80 8C.
2.2. Bacteriophage isolation and ampliﬁcation
The bacteriophages used in this study, phi F78E, phi
F258E and phi F61E, were isolated from samples of sewage,
collected randomly from Portuguese poultry houses.
Taxonomically, phi F78E and phi F61E seemed to be 16–
19 type phages belonging to Myoviridae family, yet
genetically different, and phi F258E, a T1-like Siphoviridae
phage. In vitro tests revealed 70.5% of lysis effectiveness
with a combination of these three phages on 148 APEC
strains (Oliveira et al., 2009b). The characteristics of these
phages, as well as its broad range of activity, were
considered promising and hence were chosen to conduct
in vivo phage efﬁcacy experiments in chickens.
Brieﬂy, the isolation assay comprised an overnight
incubation (37 8C) of the sewage samples in a 3–4 h culture
of the isolated E. coli strains, in Luria Bertani (LB) broth, the
supernatant centrifugation at 9000 g for 10min and
ﬁltration through 0.22mm membrane ﬁlters, and search-
ing for clear zones after spotting the resultant suspension
over the respective bacterial strain lawn. The phage
replication was performed by inoculating 10ml of
107 PFU/ml of each phage suspension in 100ml culture
of the respective host strain, 3–4 h culture in LB broth,
followed by an overnight incubation at 37 8C with shaking
(120 rpm). The resultant suspension was centrifuged at
9000 g for 10min, ﬁltered through a 0.22mmmembrane
and stored at 4 8C.The phage concentrations were determined based on
the plaque assay method described by Adams (1959). A
volume of 100ml of successive dilutions of the suspension
of each phage, mixed with 100ml of the host strain (3–4 h
culture) and 3ml of LB 0.6% melted agar, was poured onto
1.5% LB agar plates and incubated overnight at 37 8C.
2.3. Selection and preparation of the challenge material
Prior to the phi F78E efﬁcacy trials, in vivo preliminary
experiments were conducted in order to select APEC
strains able to induce severe but not sudden colibacillosis
in chickens under experimental conditions. The strain
H839E, serotypeO78,was selected to proceedwith efﬁcacy
trials. The strain, stored in Nutrient Broth (Oxoid) with 20%
glycerol, at 80 8C, was plated on MacConkey agar, and
incubated at 37 8C, overnight. One isolated colony was
picked from plates, inoculated in 10ml of LB broth, and re-
incubated at 37 8C for 3 h, just before the beginning of the
in vivo efﬁcacy experiments. A sample of this challenge
material was taken from the 3 h grown suspension, to
proceed with the determination of the bacterial concen-
tration. For that, successive dilutions of the sample were
prepared, in a sterile saline solution (0.85% NaCl), and
0.1ml of each dilution was poured onto LB agar plates and
incubated overnight at 37 8C. This procedure was per-
formed in triplicate.
2.4. Therapeutic phage cocktail composition
The phage cocktail used in this study was composed of
5.0 107 PFU/ml of each phage, phi F78E, phi F258E and
phi F61E, in LB broth.
2.5. Welfare, housing and handling
The in vivo tests performed in conﬁned experimental
rooms were designed and conducted in accordance with
principles and speciﬁc guidelines of animal welfare of the
Federation of European Laboratory Animal Science Asso-
ciations (FELASA) (Van Zutphen et al., 2001), and based on
the European Council Directive of 24 November 1986 (86/
609/EEC) guidelines, regarding the protection of animals
used for scientiﬁc experimental purposes. In all the
designed experiments, there was a great concern to
minimize the number of animals used in the experiments.
The in vivo tests were conducted to determine the
efﬁcacy of phages in treating chickens with induced
colibacillosis. Phages were administered orally, wherein
1ml of the phage suspension was dispensed into the birds’
mouth with the aid of a syringe, and by spray, directly in
the beak, through a spray nozzle set to release 1ml per ﬁne
drop scatter (Oliveira et al., 2009a), immediately after
chickens have been challengedwith an avian pathogenic E.
coli suspension.
Healthy chickens (Rhode Island Red, acquired from a
local poultry house) were housed in batteries, in two
experimental rooms, with forced air exhaustion: the birds
not exposed to phages were placed in a separate room
(named phage-free room) from that of chickens subjected
to phage treatment. Temperature and relative humidity
A. Oliveira et al. / Veterinary Microbiology 146 (2010) 303–308 305were measured and controlled during the experiments, in
order to ensure the optimal environmental conditions. A 5-
day acclimation period preceded the challenge. Feed
(commercial grower feed) and water were available for
ad libitum consumption. The birds were weighed on the
day of arrival and at the beginning of the experiment.
The efﬁcacy of the treatments was evaluated based on
mortality,morbidityandseverityof the colibacillosis lesions
(Velkers et al., 2005). Chickens that died during the
challenging period, and the ones euthanized at the end of
the trial through isoﬂurane inhalation (Close et al., 1997)
were submitted to postmortem examination. The severity of
the lesions was evaluated and scored as follows: 1, no
macroscopic lesions or thickening and opacity of the
inoculated air sac; 2, non-severe lesions in the internal
organs, not interfering in carcass quality; 3, severe and
generalised colisepticemia injuries, as ﬁbrinous aerosacu-
litis, pericarditis and perihepatitis; 4, death before eutha-
nasia. The pathology score of each group was calculated:
S(number of birds with the same score score)/total
number of birds.
Before the beginning of the trials, chickens were
monitored for the presence of other phages active against
the challenging E. coli strains. For that purpose, feces were
collected from each battery, emulsiﬁed in LB broth,
inoculated in a 3–4 h grown culture of the E. coli strain,
and incubated at 37 8C overnight with shaking (120 rpm).
After centrifugation at 9000 g for 10min and ﬁltration
through 0.2mm, the suspensionwas spotted on the bacteria
lawns (LB agar), incubated at 37 8C overnight, and checked
for clear zones. This procedure was repeated daily in the
phage-free room. The screening of phage-sensitive com-
mensal enterobacteria was also performed. Cloacae swabs
were collected from chickens, sown in several MacConkey
agar plates and incubated at 37 8C. Eight to tenpink colonies
were picked from each plate, incubated separately in 10ml
of LB broth at 37 8C for 3–4 h, and eachwas spread in a lawn
for phage sensitivity test: 10ml of phage were dropped on
plate bacteria lawns, and incubated at 37 8C overnight.
Plates were then checked for clear zones.
2.6. In vivo evaluation of phages efﬁcacy to treat colibacillosis
2.6.1. Phi F78E high phage titre suspension
In this trial, the efﬁcacy of a high phi F78E titre
suspension to control APEC infections was determined. A
total of 28 chickens of 10-week-old weighing 883.9 g in
average were randomly divided into three groups and
placed in batteries. Two groups of 12 birdswere challenged
with 0.2ml of a 3 h grown culture of 5.0 108 CFU/ml of
the APEC H839E, by injection in the left air sac.
Immediately after being challenged, one of the groups
was treated with a suspension of 1.5 109 PFU/ml phi
F78E, orally (1ml) and by spray (1ml).
The other group of 12 birds remained untreated, and
was set as the positive control. The negative control,
comprised of 4 birds, received sterile LB broth injected in
the left air sac.
The euthanasia and postmortem examinations were
performed in chickens, 7 days after being challenged with
E. coli.2.6.1.1. Postmortem screening for the presence of host
resistant strains. At the postmortem examination of the
efﬁcacy trial, infected liverswere collected from the phage-
treated group. The organs were emulsiﬁed, separately, in
LB broth. A volume of 0.1ml of the supernatant was plated
in MacConkey agar. Plates were incubated at 37 8C
overnight. Pink-red colonies were picked, inoculated into
the same selectivemedia and incubated at 37 8C overnight;
this procedure was repeated three more times.
In each of the experiments, in order to test if the strain
isolated from the carcasses remained sensitive to the
respective infecting phage, about 10 pink-red colonies
were picked from the previously incubated MacConkey
agar plates, inoculated separately in 0.6% LB agar, and
poured onto the wells of a 24-well microplate. This
procedurewas performed in duplicate and a volume of 5ml
of phage suspension was dispensed in each bacteriae lawn.
The original E. coli strain was used as positive control.
2.6.1.2. Statistical analysis. A two-sided Student’s t-test
was used, to compare groups with a signiﬁcance level of 5%
and a statistical power of 90% (a = 0.05 and p = 0.90). The
experimental unit was considered to be the chicken.
The estimated number of experimental units needed for
the trials was obtained based on Beynen et al. (2001)
statistical assumptions, in which the sample size was a
function of the difference considered meaningful between
groups from a physiological point of view, expressed as
multiples of the standard deviation that was estimated
from an anticipated individual variation ((m1m2)/s).
The individual variation was previously estimated as
10% on average, and the meaningful biological difference
between groups (P> 0.05) was set as 15%, requiring
therefore a minimum of 11 experimental units.
2.6.2. Large scale experiments
The experimental unit of this experiment was E. coli
infected ﬂocks, with high mortality rates even after
antibiotic treatment (n = 11). Dead chickens in each ﬂock
were submitted to postmortem analysis, and after conﬁr-
mation of death by colisepticemia, through evaluation of
macroscopic lesions (perihepatitis, pericarditis, aerosac-
culitis, enteritis), samples of infected organs – livers,
spleen and lungs – were collected from carcasses. Those
samples were emulsiﬁed (1:10 (v/v)) in sterile saline
solution (0.85% NaCl) and 0.1ml of supernatant was plated
on MacConkey agar. Plates were incubated overnight at
37 8C and pink-red colonies were selected. API E20 strips
were used for species conﬁrmation of the isolates.
For each isolated E. coli strain, in vitro phage lytic tests
were performed, by spotting 10ml of the cocktail suspen-
sion (phi F61E, phi F78E, and phi F258E) over the respective
bacterial lawn on LB agar. Plates were incubated overnight
at 37 8C. Clear zones indicated phages in vitro efﬁcacy to
lyse the bacteria causing the infection, in the respective
ﬂock. In these cases, the phage mixture was administered
to all the ﬂock, in a single application. A volume of 500ml
per 10,000 birds was prescribed: half of the dose was
diluted in the drinking water to be consumed in half a day
and the remaining 250ml were administered by spray,
adding a volume of 500ml of water per 1000 birds. The
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manual sprayer set to ﬁne drop deliver, and so that the
phage mixture was spread over all the chickens. The water
used in this trial was free of disinfectants or other phage
inhibitors. Mortality was recorded at the beginning of the
trial, and for 3 weeks thereafter.
3. Results
3.1. In vivo evaluation of phi F78E in treating induced
colibacillosis
The microbiological control of the birds at housing
revealed no phage particles active against the inoculated
host and no phi F78E-sensitive E. coli strains in the
chickens’ feces. The daily phage screening in the phage-
free experimental room revealed a total absence of phi
F78E phage during trials.
In the experiment, in which the concentration of phage
administered was 1.5 109 PFU/ml, the pathology score,
the morbidity and the mortality were signiﬁcantly lower
(P< 0.05) in the phage-treated group than in the untreated
group (H839E) (Fig. 1A). Lesions found in carcasses were
also less severe in the phage-treated group (Fig. 1B).
This highly concentrated phage suspension allowed, on
average, a 25.0% decrease in mortality of chickens and
41.7% in morbidity.
In the negative control group, no chicken died and no
lesions were detected in the postmortem analysis.
3.1.1. Postmortem screening for the presence of host resistant
strains
Results from this test revealed that the E. coli isolated
from chickens, receiving the phage preparation, remained
sensitive to these phages.
3.2. Large scale experiments
E. coli strains isolated from 11 ﬂocks of broiler chickens
(Rhode Island Red), 7-week-old on average, were shown, in
vitro, to be sensitive to the prepared phage cocktail. Flocks
had between 5000 and 10 000 birds. The mortality beforeFig. 1.Morbidity andmortality (%) (A) and pathology scores (B) obtained for each
H839E and treated with phi F78E; H839E (&), challenged with H839E. Scores:
lesions of colibacillosis; 3–4, acute colisepticemia. Error bars indicate a meanin
group; bsigniﬁcantly different from mortality in H839E group; and csigniﬁcantand after the phage cocktail administration was registered
and is presented in Fig. 2. The infection was considered
controlled when mortality reached values of 0.5% or less
(usual in healthy ﬂocks). In most cases, when this
condition was achieved no further data was collected.
One week after the cocktail administration, the
mortality was controlled in ﬁve ﬂocks, namely ﬂock
number 6, 8, 9, 10 and 11 (0.5%). In the following week,
ﬂock number 7 achieved the regular levels of mortality,
and by the third week, all the ﬂocks except number 5 were
controlled for colibacillosis. The exception was related to
one case (indicated with an arrow in Fig. 2), in which the
mortality decreased consistently since phage administra-
tion, from 1.52% to 0.68%. No recidivism in the mortality
rate was observed in any ﬂock until slaughter.
One case study of a broiler ﬂock (Cobb) was also made
under the described conditions, and results showed that,
besides a mortality decrease during the experiment (from
0.6% to 0.08%), the rejections at slaughter were reduced as
well, following phage administration, from 4.8% to 1.82%
(data not shown).
4. Discussion
It has been suggested that phages might be able to
reduce the densities and rates of dissemination of the
infecting populations of bacteria, to levels at which they
may be controlled by the host immune system (Levin and
Bull, 2004). Furthermore, by replicating in the infected
areas, phages should be able to control localized infections
that are relatively inaccessible via the circulatory system
as, for example, in the chickens’ air sacs. Theoretically, if a
bacteriophage reaches the site of a bacterial infection, it is
supposed to be effective in eliminating the disease
(Sulakvelidze et al., 2001; Cerveny et al., 2002; Sajjad
et al., 2004; Huff et al., 2006). These attributes make
phages powerful alternatives to antimicrobials. This idea is
shared by several phage researchers who reported
successful trials, with phages conferring high protection
levels against infections (Smith and Huggins, 1983; Smith
et al., 1987; Barrow et al., 1998; Sklar and Joerger, 2001;
Huff et al., 2002, 2003, 2004, 2005; Park and Nakai, 2003;group of chickens (n = 12). Groups: phi F78E + H839E (&), challengedwith
1, no injuries; 1–2, non-severe lesions of colibacillosis; 2–3, generalised
gful difference of 15%. aSigniﬁcantly different from morbidity in H839E
ly different from pathology scores in H839E group.
Fig. 2.Mortality rate (%)measured in 11 E. coli naturally infected ﬂocks, previously treated with antibiotics. Records were taken at the phage administration
and repeated weekly, for 3 weeks: week before phage administration (&), 1st week ( ), 2nd week ( ), and 3rd week (&).
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also recognize beneﬁts in having different phages in the
same product, enlarging the lytic spectrum and delaying
the occurrence of resistance to phages (Slopek et al., 1987;
Smith et al., 1987; Sulakvelidze et al., 2001; Goodridge and
Abedon, 2003; Huff et al., 2004; Wagenaar et al., 2005).
In this work, the in vivo efﬁcacy of phages in treating
chickens with colibacillosis was evaluated by two different
ways: ﬁrstly with a high titre phage suspension (phi F78E),
conducted in experimental rooms where birds were
artiﬁcially infected with E. coli and secondly in large scale
experiments performed on naturally infected ﬂocks with a
cocktail comprised by three phages, phi F61E, phi F78E and
phi F258E.
Three in vivo studies were previously conducted on the
therapeutic efﬁcacy of low titre suspensions, 107 PFU/ml,
of phi F61E, phi F78E and phi F258E, administered orally
and by spray, to treat APEC challenged chickens. However,
there was no efﬁcacy demonstrated, concerning mortality,
morbidity and pathological score reduction (data not
shown). This was probably based on the low titres of phage
used, attending the severe stage of the induced infection in
chickens.
In a subsequent study, the therapeutic effectiveness of
one of the phages, phi F78E, administered orally and by
spray at 109 PFU/ml was demonstrated, resulting, on
average, in a 25.0% reduction in themortality and 41.7% in
the morbidity of the treated birds. Results are consistent
with most of the published research in this ﬁeld. Several
experiments have been shown that the efﬁcacy of therapy
with phages is highly dependent on whether the phage
titre administered provides or not a sufﬁcient number of
particles to the site of the infection (Huff et al., 2002,
2006).
On the other hand, results obtained in the experiments
performed in ﬂocks naturally infected with pathogenic E.coli revealed that, when a low titre phage product (three
phage cocktail containing 5.0 107 PFU/ml) was adminis-
tered, in a single application, orally and by spray, phages
were able to control colibacillosis by avoiding chickens’
losses before severe lesions or septicemia occur, allowing a
signiﬁcant mortality reduction in no more than 3 weeks in
all ﬂocks, and also a decrease of carcass rejection at
slaughter in one tested ﬂock (data not shown).
It is important to stress that, unlike experimental
conditions, in naturally-occurring infections the transmis-
sion of the infectious agent happens gradually and
horizontally from one chicken to another, and birds are
not synchronized at the same stage of infection (Huff et al.,
2005). So, despite the recognized importance of a high
phage concentration for successful therapy (Huff et al.,
2006), it is possible that, in naturally-occurring infections
in which chickens are in different stages of colibacillosis, a
lower titre phage product becomes effective as well, by
controlling the earlier stages of the infection and avoiding
the progressive transmission in the ﬂock. The product
must, nevertheless, be administered as soon as possible,
after diagnosis.
The administration of a low phage titre product is
advantageous, since it is more feasible to produce large
volumes of low concentrated phage suspensions.
Overall, this work demonstrated that the phages under
study are able to act therapeutically in early stages of
pathogenic E. coli infections, at low doses, when adminis-
tered orally and by spray.
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